Skip to Content
Merck
  • Reduced subcutaneous adipogenesis in human hypertrophic obesity is linked to senescent precursor cells.

Reduced subcutaneous adipogenesis in human hypertrophic obesity is linked to senescent precursor cells.

Nature communications (2019-06-23)
Birgit Gustafson, Annika Nerstedt, Ulf Smith
ABSTRACT

Inappropriate expansion of the adipose cells in the subcutaneous adipose tissue (SAT) is a characteristic of hypertrophic obesity and of individuals with genetic predisposition for T2D (first-degree relatives; FDR). It is associated with insulin resistance, a dysfunctional, adipose tissue and reduced adipogenesis. We examined the regulation of adipogenesis in human SAT precursor cells and found ZNF521 to be a critical regulator of early adipogenic commitment and precursor cells leaving the cell cycle. However, neither altered upstream signalling nor lack of SAT progenitor cells could explain the reduced adipogenesis in hypertrophic obesity. Instead, we show that progenitor cells undergoing poor differentiation are characterized by senescence, inability to suppress p53/P16INK4 and secretion of factors reducing adipogenesis in non-senescent cells. We found aging, FDR and established T2D to be associated with increased progenitor cell senescence, reduced adipogenesis and hypertrophic expansion of the SAT adipose cells.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-ZNF521 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution, Ab1
Sigma-Aldrich
Anti-ZNF521 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution